Literature DB >> 14620522

Inactivation and aggregation of beta-galactosidase in lyophilized formulation described by Kohlrausch-Williams-Watts stretched exponential function.

Sumie Yoshioka1, Shinsuke Tajima, Yukio Aso, Shigeo Kojima.   

Abstract

PURPOSE: To examine whether the empirical Kohlrausch-Williams-Watts (KWW) equation is applicable not only to protein aggregation but also to protein denaturation in lyophilized formulations. Lyophilized beta-galactosidase (beta-GA) formulations containing polyvinylalcohol and methylcellulose were used as model formulations. The possibility of predicting storage stability based on the temperature dependence of the estimated parameters of inactivation/aggregation--time constant (tau) and its distribution (beta) is discussed.
METHODS: Protein aggregation in lyophilized beta-GA formulations at 10-70 degrees C and 6-43% relative humidity was determined as a function of time by size exclusion chromatography. Enzyme activity was also determined using 2-nitrophenyl-beta-D-galactopyranoside as a substrate.
RESULTS: Inactivation and aggregation of beta-GA were describable with the empirical KWW equation, regardless of whether the temperature was above or below the NMR relaxation-based critical mobility temperature (Tmc) or whether protein molecules with different degrees of deformation resulting from stresses during lyophilization exist in formulation. The estimated beta parameter for protein aggregation creased rapidly as temperature increased beyond Tmc becausethe mobility of polymer molecules increased in the initial stages of glass transition. The time required for 10% enzyme to aggregate (t90) calculated from the tau and beta parameters exhibited a change in temperature dependence gradient near Tmc. In contrast, t90 for protein inactivation exhibited temperature dependence patterns varying withthe excipients.
CONCLUSIONS: The t90 calculated from the estimated tau and beta parameters was found to be a useful parameter for evaluating the stability of lyophilized beta-GA formulations. The prediction of t90 by extrapolation was possible in the temperature range in which beta did not rapidly vary with temperature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620522     DOI: 10.1023/a:1026151721212

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Interpretation of relaxation time constants for amorphous pharmaceutical systems.

Authors:  S L Shamblin; B C Hancock; Y Dupuis; M J Pikal
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

2.  Usefulness of the Kohlrausch-Williams-Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

3.  Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.

Authors:  Jinsong Liu; Daniel R Rigsbee; Carol Stotz; Michael J Pikal
Journal:  J Pharm Sci       Date:  2002-08       Impact factor: 3.534

4.  Enthalpy relaxation in binary amorphous mixtures containing sucrose.

Authors:  S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

5.  The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

Authors:  M J Pikal; D R Rigsbee
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

6.  Purification and properties of beta-galactosidase from Aspergillus oryzae.

Authors:  Y Tanaka; A Kagamiishi; A Kiuchi; T Horiuchi
Journal:  J Biochem       Date:  1975-01-01       Impact factor: 3.387

7.  The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

8.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  8 in total
  8 in total

1.  Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.

Authors:  Danforth P Miller; David Lechuga-Ballesteros
Journal:  Pharm Res       Date:  2006-09-06       Impact factor: 4.200

2.  Advantage of being a dimer for Serratia marcescens endonuclease.

Authors:  Chuanying Chen; Kurt Krause; B Montgomery Pettitt
Journal:  J Phys Chem B       Date:  2009-01-15       Impact factor: 2.991

3.  Effect of sugars on the molecular motion of freeze-dried protein formulations reflected by NMR relaxation times.

Authors:  Sumie Yoshioka; Kelly M Forney; Yukio Aso; Michael J Pikal
Journal:  Pharm Res       Date:  2011-06-25       Impact factor: 4.200

4.  Colloidal Gels for Guiding Endothelial Cell Organization via Microstructural Morphology.

Authors:  Yuan Yuan; Sukanya Basu; Meng Huisan Lin; Shruti Shukla; Debanjan Sarkar
Journal:  ACS Appl Mater Interfaces       Date:  2019-08-21       Impact factor: 9.229

5.  Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.

Authors:  Sumie Yoshioka; Tamaki Miyazaki; Yukio Aso; Tohru Kawanishi
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

6.  Effects of dimerization of Serratia marcescens endonuclease on water dynamics.

Authors:  Chuanying Chen; Brian W Beck; Kurt Krause; Tiffany E Weksberg; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2007-02-15       Impact factor: 2.505

7.  A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.

Authors:  Sumie Yoshioka; Yukio Aso
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

Review 8.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.